This new book on vascular malformations brings together international experts to present advances and discuss controversies in the multidisciplinary management of patients with congenital vascular malformations.

Major advances in recent years in medical genetics, and tremendous progress in the fields of imaging and minimally invasive percutaneous interventions have revolutionized both evaluation and management of vascular malformations. The six major parts of this state of the art book ensure that the reader has the most up to date valuable clinical information to ensure the delivery of world class clinical practice. Beautifully illustrated with color line drawings, numerous photographs and informative tables, the advances and controversies of the full spectrum of vascular malformations are presented in 90 definitive chapters.

Vascular Malformations brings new information and unparalleled insights to vascular specialists and physicians, trainees and allied health professionals who participate in the care of patients with vascular malformations, either in a private practice setting or at a major institution in an interdisciplinary vascular center.

part 1|1 pages

Congenital Vascular Malformations (CVMs) in General

section Section 1|1 pages

Definition and Classification

chapter 1|2 pages

ISSVA classification: Controversy with the benefit and liability

ByRaul Mattassi

chapter 2|4 pages

Hamburg classification: Controversy with the benefit and liability

ByPeter Gloviczki, David J. Driscoll

chapter 4|4 pages

Consensus on contemporary classification

ByByung-Boong Lee, Leonel Villavicencio

section Section 3|1 pages


chapter 9|3 pages

Importance of interdisciplinary team approach for evaluation and management of vascular malformations

ByMegha M. Tollefson, Peter Gloviczki, David J. Driscoll

chapter 10|8 pages

How will genetics influence management of vascular malformations?

ByFrancine Blei

part 2|1 pages

Arteriovenous Malformations (AVMs)

section Section 4|1 pages

Definition and Classification

section Section 5|1 pages


section Section 6|1 pages

Management: 1

chapter 19|5 pages

How much is too much for arteriovenous malformation management?

ByYoung-Wook Kim

chapter 20|4 pages

Ethanol sclerotherapy: Is it gold standard for arteriovenous malformation management?

ByIris Baumgartner, Mihai Constantinescu, Jochen karl Rössler, Hendrik von Tengg-Kobligk

chapter 21|5 pages

N-butyl cyanoacrylate versus Onyx embolotherapy

ByFuruzan Numan

section Section 7|1 pages

Management: 2

part 3|1 pages

Venous Malformations

section Section 8|1 pages

Definition and Classification

chapter 26|3 pages

Capillary and cavernous hemangioma and venous malformations

ByByung-Boong Lee, James Laredo

section Section 9|1 pages


section Section 10|1 pages

Management: 1

chapter 32|3 pages

Do all venous malformations require treatment?

ByKurosh Parsi, Mina Kang

chapter 33|3 pages

How much is too much for venous malformation management?

ByPier Luigi Antignani

chapter 34|5 pages

What is the first option for venous malformation management?

BySarah Bernhard, Aleksandra Tuleja, Jochen Karl Rössler, Iris Baumgartner

chapter 36|2 pages

Foam sclerotherapy: First option for venous malformations?

ByKurosh Parsi, Mina Kang

section Section 11|1 pages

Management: 2

chapter 40|3 pages

To what extent should anticoagulation therapy be considered for venous malformations?

ByAlfonso Tafur, Evi Kalodiki, Jawed Fareed

part 4|1 pages

Lymphatic Malformations

section Section 12|1 pages

Definition and Classification

chapter 44|4 pages

Confusion on terminology: Primary lymphedema and lymphangioma (lymphatic malformation)

ByJames Laredo, Byung-Boong Lee

chapter 45|3 pages

Contemporary diagnosis of primary lymphedema and lymphatic malformation

ByStanley G. Rockson

chapter 46|4 pages

Clinical staging of lymphedema: How practical is it for clinical management of primary lymphedema?

BySandro Michelini, Alessandro Fiorentino, Alessandro Failla, Giovanni Moneta

chapter 47|3 pages

Laboratory (lymphoscintigraphic) staging guideline?

ByByung-Boong Lee, James Laredo

section Section 13|1 pages


chapter 51|3 pages

Indocyanine green fluorescent lymphography: Clinical implementation

ByTakumi Yamamoto

chapter 52|5 pages

Oil contrast lymphangiography: New role for the surgical candidate?

ByFrancesco Boccardo, Sara Dessalvi, Corrado Cesare Campisi, Corradino Campisi

chapter 53|3 pages

Fluorescent microlymphangiography: Controversy, confusion, and neglected problems

ByClaudio Allegra, Michelangelo Bartolo, Salvino Bilancini

chapter 54|2 pages

Can indocyanine green replace role of lymphoscintigraphy?

ByTakumi Yamamoto

section Section 14|1 pages

Management: 1–Primary Lymphedema

chapter 56|3 pages

Manual lymphatic drainage: Myth?

ByIsabel Forner-Cordero, Jean-Paul Belgrado

chapter 57|5 pages

Compression therapy: Optimal pressure? Bandage versus stocking

ByIsabel Forner-Cordero, Jean-Paul Belgrado

chapter 59|5 pages

Reconstructive surgery: Lymphovenous anastomosis versus lymph node transplantation—Can they stay as independent therapy options?

ByCorradino Campisi, Francesco Boccardo, Melissa Ryan, Michele Maruccia, Fabio Nicoli, Pietro Di Summa, Corrado Cesare Campisi

chapter 60|2 pages

Excisional surgery: When and how much it can be incorporated

ByJustin Chin-Bong Choi, James Laredo, Byung-Boong Lee

chapter 62|4 pages

How much pharmacological therapy can be incorporated in primary lymphedema management?

ByVaughan Keeley, Neil Piller

chapter 63|3 pages

What is difference in management of primary lymphedema between adults and children, and how much?

ByCristobal M. Papendieck, Miguel A. Amore

chapter 64|2 pages

How to manage lipedema involved with primary lymphedema?

ByGyőző Szolnoky

chapter 66|3 pages

How to assess efficacy of lipedema management involved in lymphedema

ByGyőző Szolnoky

chapter 68|4 pages

Liposuction: Can it be applied to management of lipedema?

ByRobert J. Damstra, Tobias Bertsch

section Section 15|1 pages

Management: 2–Lymphangioma

chapter 69|4 pages

How to manage lymphatic leakage involved in lymphangioma?

ByXi Yang, Xiaoxi Lin, Ningfei Liu

chapter 70|4 pages

How to manage recurrent infections involved with lymphangioma?

ByXi Yang, Xiaoxi Lin, Ningfei Liu

chapter 72|2 pages

Pharmacological considerations for lymphatic malformation management

ByStanley G. Rockson

chapter 73|4 pages

How much different should the management of lymphangioma among the pediatric/neonatal age group be?

ByCristobal M. Papendieck, Miguel Amore

chapter 74|3 pages

Peculiarities in surgical treatment in childhood: Can we ignore?

ByJuan Carlos López GutiÉrrez

part 5|1 pages

Combined vascular malformations: Hemolymphatic malformations/Klippel-Trenaunay syndrome

section Section 17|1 pages

Management: 1

chapter 77|3 pages

How to decide priority for treatment among congenital vascular malformation components

ByJames Laredo, Byung-Boong Lee

chapter 78|8 pages

Management of vascular bone syndrome: How aggressive and when?

ByJong Sup Shim, Young-Wook Kim

chapter 79|4 pages

How aggressively should varicose veins be managed in Klippel–Trenaunay syndrome?

BySergio Gianesini, Erica Menegatti

chapter 80|2 pages

How aggressive should management be of indolent stasis ulcer in Klippel–Trenaunay syndrome?

BySergio Gianesini, Erica Menegatti

section Section 18|1 pages

Management: 2

chapter 83|4 pages

How to manage coagulopathy in Klippel–Trenaunay syndrome?

ByAlfonso Tafur, Evi Kalodiki, Jawed Fareed

chapter 84|4 pages

Klippel–Trenaunay syndrome: Pain and psychosocial considerations

ByJamison Harvey, Megha M. Tollefson, Peter Gloviczki, David J. Driscoll

part 6|1 pages

Capillary Malformations (CMs)